Philips is parting ways with its worldwide emergency care business, including its catalog of automated external ...
Philips has signed an agreement for the sale of its Emergency Care business to US-based investment firm Bridgefield Capital.
More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful ...
The deal includes a licensing agreement that allows the sold business to use the Philips brand for up to 15 years.